WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
YOHO GROUP (02347) spent HK$365,400 to repurchase 522,000 shares on January 26th.
Domestic computing power launches a major counterattack! ILUVATAR COREX (09903) unveils fourth-generation architecture "overtake" roadmap, performance surpassing NVIDIA, landing 300+ benchmark customers, changing the landscape of the trillion-dollar track.
BGMC (01693) has completed the issuance of 3.61 million shares for placement.
YOHO GROUP (02347) spent HK$365,400 to repurchase 522,000 shares on January 26th.
Domestic computing power launches a major counterattack! ILUVATAR COREX (09903) unveils fourth-generation architecture "overtake" roadmap, performance surpassing NVIDIA, landing 300+ benchmark customers, changing the landscape of the trillion-dollar track.
BGMC (01693) has completed the issuance of 3.61 million shares for placement.
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026
